loading
Scinai Immunotherapeutics Ltd Adr stock is traded at $0.87, with a volume of 31,004. It is down -4.50% in the last 24 hours and down -42.38% over the past month. Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
See More
Previous Close:
$0.911
Open:
$0.91
24h Volume:
31,004
Relative Volume:
0.34
Market Cap:
$2.77M
Revenue:
-
Net Income/Loss:
$-9.29M
P/E Ratio:
-0.1673
EPS:
-5.2
Net Cash Flow:
$-9.42M
1W Performance:
-11.09%
1M Performance:
-42.38%
6M Performance:
-69.58%
1Y Performance:
-71.19%
1-Day Range:
Value
$0.86
$0.91
1-Week Range:
Value
$0.86
$1.07
52-Week Range:
Value
$0.86
$6.18

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Name
Name
Scinai Immunotherapeutics Ltd Adr
Name
Phone
972-8-9302529
Name
Address
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCNI's Discussions on Twitter

Compare SCNI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SCNI
Scinai Immunotherapeutics Ltd Adr
0.87 3.16M 0 -9.29M -9.42M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Latest News

pulisher
Nov 14, 2025

SCNI | Scinai Immunotherapeutics Ltd. ADR SEC Filings - MarketWatch

Nov 14, 2025
pulisher
Nov 13, 2025

Scinai Immunotherapeutics schedules annual meeting for December 22 - Investing.com

Nov 13, 2025
pulisher
Nov 13, 2025

Scinai Immunotherapeutics schedules annual meeting for December 22 By Investing.com - Investing.com South Africa

Nov 13, 2025
pulisher
Nov 13, 2025

Cash per share of Scinai Immunotherapeutics Ltd. Sponsored ADR – BER:2F5 - TradingView

Nov 13, 2025
pulisher
Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing By Investing.com - Investing.com South Africa

Oct 06, 2025
pulisher
Oct 06, 2025

Scinai receives $246,000 grant to expand biotech manufacturing - Investing.com

Oct 06, 2025
pulisher
Sep 03, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports First-Half 2025 Results, Strengthened Cash Position - Barchart.com

Sep 03, 2025
pulisher
Sep 02, 2025

Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Barchart.com

Sep 02, 2025
pulisher
Aug 26, 2025

Scinai Immunotherapeutics (NASDAQ:SCNI) Trading Down 3.8% – Here’s What Happened - Defense World

Aug 26, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier - Barchart.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Immunotherapeutics stock soars on promising skin disease drug data - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment By Investing.com - Investing.com Canada

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai’s PC111 antibody shows promise for pemphigus treatment - Investing.com India

Jul 29, 2025
pulisher
Jul 29, 2025

ICICI Bank Ltd. ADR (IBN) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 29, 2025
pulisher
Jul 29, 2025

Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Benzinga

Jul 29, 2025
pulisher
Jul 13, 2025

Scinai Immunotherapeutics (SCNI) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat

Jul 13, 2025
pulisher
Jun 19, 2025

Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 19, 2025
pulisher
Jun 04, 2025

Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks

Jun 02, 2025
pulisher
Apr 01, 2025

Military Breakthrough: BrainChip and Raytheon Land $1.8M Air Force Deal for Next-Gen Radar - Stock Titan

Apr 01, 2025
pulisher
Mar 27, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell - The Globe and Mail

Mar 27, 2025
pulisher
Dec 16, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - The Globe and Mail

Dec 16, 2024
pulisher
Jun 07, 2024

Scinai regains Nasdaq compliance, eyes EIB loan conversion - Investing.com

Jun 07, 2024
pulisher
May 06, 2024

Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com

May 06, 2024
pulisher
Mar 27, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 27, 2024
pulisher
Feb 12, 2024

Scinai Immunotherapeutics (SCNI) Short Interest & Short Float | Updated Nov 2025 - MarketBeat

Feb 12, 2024
pulisher
Oct 30, 2023

Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023 - Barchart.com

Oct 30, 2023
pulisher
Sep 20, 2023

SCNI Stock Price and Chart — NASDAQ:SCNI - TradingView

Sep 20, 2023
pulisher
Sep 18, 2023

Scinai Immunotherapeutics (SCNI) Stock Price, News & Analysis - MarketBeat

Sep 18, 2023
pulisher
Sep 11, 2023

Scinai Immunotherapeutics Ltd Share Price ADR Each Representing 400 Ord Shares SPON - Hargreaves Lansdown

Sep 11, 2023
pulisher
Aug 20, 2023

What is the current Price Target and Forecast for Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) - Zacks Investment Research

Aug 20, 2023
pulisher
Nov 02, 2019

SCNI Stock Price | Scinai Immunotherapeutics Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Nov 02, 2019

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Cap:     |  Volume (24h):